Sacha is an experienced venture capital investor, board member, CEO and company builder. She has over 20 years of experience in venture investing, start-up leadership, biotech CEO, business development and industry research. Currently she’s building new biotech companies and advising biotech funds. Previously, Sacha was the Head of Genesis Labs and a Senior Partner at Takeda Ventures where she focused on early-stage biotech investments. She led investments in, and was on the board of, hC Bioscience, Larkspur Biosciences, and Egle Therapeutics. She also served as a member of the board of directors for Ribon, Ensoma, Crescendo and Oak Hill Bio. She was the CEO of Biosys, a venture-backed clinical stage GI company, and led several life science investments at Inventages. She has been an advisor and director for various life science companies, incubators/ accelerators, and investors. Prior to Inventages, Sacha was an early stage investor focused on innovation and investment at Archangels and BDC Capital. Sacha holds a BSc Honours in Chemistry from the University of British Columbia, an MSc in Biotechnology from Johns Hopkins University, an MBA from Simon Fraser University and is a Kauffman Fellow.